tPrednisone (20- 40 mg/day) or prednisone (5-10 mg/day) and cyclosporin A (5-10 mg/kg/day).
Does autoimmunity to S-antigen play a rok in Fuchs' heterochromic cyclitis? Cellular immune reactivity against human S-antigen was tested in a two step migration inhibition assay, as described in detail earlier. 23 In the first step of this assay mononuclear cells were incubated with the test antigen. Subsequently the cell free supernatant was tested in a second step for the presence of MIF activity using the human monocytoid U937 cell line as indicator cells.
For the first step, mononuclear cells were isolated from heparinised blood obtained from the patients using density gradient centrifugation on Ficoll-Paque (Pharmacia, Uppsala, Sweden). Cells from one or more controls were always tested on the same day as the patient cells. The cells were washed twice and adjusted to 2 5 x 101 cells per ml culture medium (RPMI 1640 supplemented with 25 mM HEPES, 100 U/ml penicillin, 0-1 mg/ml streptomycin (Gibco Ltd, Paisley, Scotland) and 10% heat inactivated pooled human serum from non-transfused healthy male donors (Central Laboratory of the Blood Transfusion Service, Amsterdam, The Netherlands). One ml aliquots were dispensed into 10 ml culture tubes. One tube served as medium control for spontaneous MIF production, concanavalin-A (Con-A, 25 ug/ml) was added to a second tube to test the general mitogenic responsiveness of the cells, and purified human S-antigen (5 ug/ml) was added to a third tube. The tubes were incubated for 20 hours in a humidified incubator at 37°C and 5% CO2. Cell free supernatants were harvested by centrifugation (10 minutes, 1200 g) and assayed directly for the presence of MIF or stored at -20°C until use.
For the second step of the assay, a human monocytoid cell (U937) line To determine the specificity of the cellular immune response to S-antigen in the patients with Fuchs' heterochromic cyclitis, blood samples of these 13 patients were also tested for their cellular immune response to the 54 kD corneal antigen, as described by van der Gaag et al. 24 Seven of the 13 patients had a positive cellular immune response to this (bovine) 54 kD antigen: three ofthese seven patients also showed a sensitisation to S-antigen.
Discussion
Fuchs' heterochromic cyclitis is generally classified as a chronic low grade anterior uveitis. The high percentage of patients with Fuchs' heterochromic cyclitis having a positive cellular autoimmune response to retinal S-antigen, compared with other anterior uveitis patients and healthy controls, is therefore remarkable. It supports the hypothesis of Arffa and Schlaegel3 that autoimmune reactions against retinal (S-)antigen(s) may play a role in the pathogenesis of Fuchs' heterochromic cyclitis. Of the 13 patients we tested, two had retinal scars: one with a toxoplasmosis-like scar had a negative response and one patient with a non-specific retinal scar had a positive cellular immune response to S-antigen. These numbers were too small to conclude that there was a possible association between retinal autoimmunity and chorioretinal scars in Fuchs' heterochromic cyclitis.
Nussenblatt et aP' reported a higher incidence (40%) of cellular immune reactivity against S-antigen in patients with ocular toxoplasmosis than in our series. Such a discrepancy may be due to the fact that they used a different cellular immune assay; the lymphocyte transformation test (LTT). We used the MIF assay because it correlates better with type IV allergic reactions (that is, delayed type hypersensitivity (DTH) response) than the LTT and may thus be more appropriate to study presumed autoimmune reactivity.26
As reported earlier,23272' a significantly higher percentage of the patients with (pan and) posterior uveitis had a positive cellular immune response to S-antigen compared with healthy controls. These results, however, are in disagreement with more recent studies in which no significant differences were found, and normal individuals also had circulating antibodies233032 and T cells2"3' sensitised to retinal (S)-antigen(s). Some discrepancy may be attributed to a different procedure used to purify and obtain the S-antigen: different received systemic steroids (20- 
